Oxford Nanopore Technologies (LON:ONT) Stock Price Down 0.2% – Here’s Why

Oxford Nanopore Technologies plc (LON:ONT)’s stock price was down 0.2% during trading on Tuesday . The company traded as low as GBX 134.10 and last traded at GBX 142.97. Approximately 1,983,077 shares changed hands during trading, a decline of 80% from the average daily volume of 9,874,966 shares. The stock had previously closed at GBX 143.20.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada reissued an “outperform” rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Oxford Nanopore Technologies currently has an average rating of “Moderate Buy” and a consensus price target of GBX 218.60.

Oxford Nanopore Technologies Stock Down 0.2%

The company has a current ratio of 3.56, a quick ratio of 6.01 and a debt-to-equity ratio of 8.96. The firm has a market capitalization of £1.39 billion, a PE ratio of -9.47 and a beta of 0.87. The firm has a 50-day moving average of GBX 119.18 and a two-hundred day moving average of GBX 129.67.

Oxford Nanopore Technologies (LON:ONT) last issued its earnings results on Monday, March 2nd. The company reported GBX (15.10) earnings per share for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.

Insider Buying and Selling

In other Oxford Nanopore Technologies news, insider Nick Keher sold 22,993 shares of the firm’s stock in a transaction dated Tuesday, April 14th. The stock was sold at an average price of GBX 108, for a total value of £24,832.44. Insiders bought 22,678 shares of company stock valued at $2,563,129 over the last 90 days. Company insiders own 2.33% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.